Patient enrollment advancing in SERENITY At-Home Phase 3 trial of BXCL501 for acute treatment of agitation associated with ...

Using a multi-strain probiotic formulation, researchers conducted a double-blind, randomized, placebo-controlled trial aimed at improving psychiatric and cognitive symptoms, intestinal permeability, ...

Holder of an innovative diagnostic support technology, recognized by the Food and Drug Administration (FDA) as a major ...

New research pinpoints 298 parts of the genome associated with higher risk of bipolar disorder. This could lead to better ...

The vast majority of people in psychosis aren’t violent—but Cohen Miles-Rath was. Here's what that can teach us about mental ...

Inside North Carolina prisons, 13 inmates killed themselves last year. Three more died in January. State officials say they ...

Police in Clayton County are asking for the public’s help locating a missing woman. Police said 32-year-old Madison Ashley ...

Usually described as a splitting or multiple personality disorder, the concept of schizophrenia is not entirely but rather a ...

According to new research published by psychiatry professor Stephen M. Stahl, artist Jackson Pollock clearly incorporated ...

A woman told a police officer she was “running for her life” after hearing she was charged with causing the death of another driver in a bizarre police interview.

Reviva Pharmaceuticals Holdings, Inc. (NASDAQ:RVPH – Get Free Report) has earned a consensus rating of “Buy” from the seven brokerages that are presently covering the firm, Marketbeat Ratings reports.